Field Medical announced today that it began the first-in-human study of its FieldForce pulsed field ablation (PFA) system. The company began its study evaluating FieldForce at Na Homolce Hospital in Prague, Czech Republic. It expects the VCAS study to enroll up to 60 patients at up to five sites around the world. Cardiff-by-the-Sea, … [Read more...] about Farapulse founder’s Field Medical begins first-in-human pulsed field ablation trial
Field Medical
The 10 most-read catheter-based innovation stories of 2023
This year was a year of firsts for catheter-based innovations, most notably for renal denervation and pulsed field ablation. ReCor Medical won an FDA panel nod for its renal denervation system in August. The panel voted in favor of the safety and efficacy of its Paradise ultrasound renal denervation (RDN) system for treating hypertension. The … [Read more...] about The 10 most-read catheter-based innovation stories of 2023
Farapulse founder’s Field Medical raises $14M for next-gen cardiac ablation tech
Field Medical announced today that it closed an oversubscribed seed round with investments reaching $14 million. Private investors led the funding for the Cardiff-by-the-Sea, California-based cardiac ablation technology developer. Multiple strategic investors also joined the round. The company earmarked the funds to support … [Read more...] about Farapulse founder’s Field Medical raises $14M for next-gen cardiac ablation tech